Both in Pharmaceuticals
Heron Therapeutics vs Rafael Holdings
Over the past year HRTX returned −75.0% and RFL returned −25.9%; their daily moves had a correlation of 0.01.
HRTX −75.0% RFL −25.9%Growth of $1, one year, split-adjusted
| Metric | HRTX | RFL |
|---|---|---|
| Price | $0.2951 | $1.00 |
| Market cap | $56.0M | $52.2M |
| Today | +6.27% | −7.41% |
| 1 month | −15.1% | −35.1% |
| 6 months | −75.8% | −20.0% |
| Year to date | −77.3% | −15.3% |
| 1 year | −74.1% | −25.9% |
| Revenue growth (YoY) | +1.3% | −30.3% |
| Gross margin | 69.3% | 94.7% |
| Net margin | −14.6% | −3760.7% |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | 59.7× |
| Net cash | -$100.0M | $21.5M |
| Dividend yield | — | — |
| Volatility (60d) | 116.6% | 113.7% |
| Short % of float | 25.7% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).